4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
IN VIVO REPROGRAMMING: A NOVEL ROUTE TO BRAIN REPAIR (iN-BraiN)
Date du début: 1 mars 2013, Date de fin: 28 févr. 2018,
Recent progress on direct re-programming into functional neurons provides a new approach towards cell-based therapy for neurodegenerative disorders. The induced neurons (iNs) are a novel type of cell resulting from rapid and remarkable conversion of somatic cells into subtype-specific functional neurons. Importantly they are non-proliferating which make them interesting alternatives to induced plu ...
Voir le projet
1
Participant partenaire
TERMINÉ
European stem cell consortium for neural cell replacement, reprogramming and functional brain repair (Neurostemcellrepair)
Date du début: 1 oct. 2013, Date de fin: 30 sept. 2017,
Neurostemcellrepair aims at taking human stem cells through the final steps toward clinical application in cell replacement therapy for neurological disorders. PD will be taken as the prototypical disease because stem cell therapy is now close to clinical translation. Moreover, we will tackle next generation issues pertaining to stem cells at a basic level and develop new approaches and novel cell ...
Voir le projet
13
Participants partenaires
TERMINÉ
"From Brain Gene Transfer Towards Gene Therapy: Pharmacological Assessment of AAV, CAV and LVV" (BRAINVECTORS)
Date du début: 1 nov. 2012, Date de fin: 31 oct. 2016,
"BRAINVECTORS aims devising new gene therapy(GT)-based treatments for Parkinson’s and other neurodegenerative diseases, in substitution of current systemic treatments, by delivering neurotrophic factors (GDNF) into the CNS with new vectors derived from adeno-associated (AAV), canine adenoviruses (CAV) and lentiviruses (LV) with inducible gene expression.Although AAV, CAV and LVV are considered acc ...
Voir le projet
12
Participants partenaires
TERMINÉ
European Consortium for Stem Cell Therapy for Neurodegenerative Diseases (NEuroStemCell)
Date du début: 1 déc. 2008, Date de fin: 31 mai 2013,
The NEuroStemCell consortium will foster collaboration between leading European experimental and clinical researchers in order to maximise the prospects for successful clinical trials of stem cell therapy for Parkinson's (PD) and Huntington's (HD) Disease. The activities will be driven by a Clinical WorkPackage (WP), which will set the requirements, and monitor and guide advances in development of ...
Voir le projet